Home
ยป
CymaBay Therapeutics
Skip to content
FinSMEs
REAL TIME VC & PRIVATE EQUITY DEALS AND NEWS
Search for:
Facebook
Twitter
Linkedin
Navigation
Site navigation
USA
UK
Germany
France
Canada
India
Italy
Home
CymaBay Therapeutics
CymaBay Therapeutics
USA
Gilead Sciences Completes Acquisition of CymaBay, for Approximately $4.3 Billion
Sign-up now to the Daily Newsletter